#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Pituitary-dependent Cushing's syndrome Hyperinsulinism Acute hepatic failure Adult T-cell lymphoma/leukaemia refractory SAPHO syndrome Myelodysplastic syndrome Malignant glioma Angiosarcoma recurrent Adenoid cystic carcinoma Synovial sarcoma recurrent Chronic inflammatory demyelinating polyradiculoneuropathy Metastases to peritoneum Meningococcal immunisation Duchenne muscular dystrophy gene carrier More trials…

    Learn about Rare Diseases

    Alexander disease – Treatment Glycogen storage disease type I – Life with Disease Glomerulonephritis membranoproliferative – Treatment Myelodysplastic syndrome – Treatment IgA nephropathy – Life with Disease Haemophilia A without inhibitors Epidermolysis bullosa – Basic Information Angiosarcoma recurrent Haemophagocytic lymphohistiocytosis – Trials in Disease Mucopolysaccharidosis I – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bisoprolol Fumarate Gs-5718-03 Clonazepam TUB-030 Sacituzumab Tirumotecan Mogamulizumab Ranolazine Mk-1088 CHONDROITIN SULFATE SODIUM Zidovudine Belimumab Fingolimod Hydrochloride Sodium Glycocholate Alemtuzumab Sodium Phosphate Dodecahydrate Sxr1096 Adct-402 Paroxetine Hydrochloride Folic Acid Tadalafil More therapies…

    Learn about Your Condition

    Chronic disease Deafness Myxoid liposarcoma Oedema Adrenogenital syndrome Iron deficiency Chronic myeloid leukaemia Iron deficiency anaemia Acute HIV infection Autoimmune uveitis Hypertension Haemophilia Infantile spasms Pyrexia Primary biliary cholangitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Gene Therapy GNT0003 for Patients with Severe Crigler-Najjar Syndrome Requiring Phototherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Crigler-Najjar syndrome
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 2/8 Containing The Human Ugt1A1 Gene
    • Amoxicillin Sodium
    • Bromhexine Hydrochloride
    France Italy The Netherlands

  • Study on Stopping CDK4/6 Inhibitors in Patients with Metastatic HR Positive, HER2 Negative Breast Cancer Using Abemaciclib, Letrozole, and Fulvestrant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    Germany

  • Study on Reducing or Stopping Immunosuppression with Tacrolimus and Ciclosporin in Patients with Late Kidney Transplant Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Ciclosporin
    • Tacrolimus
    Spain

  • Study on the Effects of Amiloride in Patients with Chronic Kidney Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • Amiloride Hydrochloride Dihydrate
    • Placebo
    Denmark

  • Study on Advanced Laryngeal and Hypopharyngeal Cancer: Comparing Docetaxel, Cisplatin, and Pembrolizumab for Patients Eligible for Laryngectomy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Laryngeal cancer
    • Squamous cell carcinoma of the hypopharynx
    Investigated Drugs:
    • Cisplatin
    • Dexamethasone
    • Docetaxel
    Germany

  • Study on the Effectiveness of Trastuzumab Deruxtecan in Patients with HER2-Positive Oligometastatic Breast Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    France Italy The Netherlands Spain Sweden
Previous Page
1 … 549 550 551 552 553 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!